Trial intelligence / Profile preview

Alpha Bright serum vs 2% hydroquinone cream for melasma in Thailand

TCTR20250217008Phase 4Recruiting

Sponsor
Faculty of Medicine Siriraj Hospital, Mahidol University
Start
Sep 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of hydroquinone in melasma, sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Sep 2022; status: recruiting.

02

Drugs

hydroquinone
03

Conditions

melasma

Beyond the preview

Go deeper on TCTR20250217008.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20250217008.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call